Orphan drug research, what is at stake for industry and health insurance?

被引：0
|
作者：
Noel, Alain
机构：
来源：
ACTUALITES PHARMACEUTIQUES | 2014年 / 53卷 / 535期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [21] Health 'Insurance': What Is It Good For?
    McCarthy, Michael
    NATION, 2009, 288 (21) : COVER2 - +
  • [22] Governance for health, wellbeing and sustainability what is at stake Preface
    Kickbusch, Ilona
    GLOBAL HEALTH PROMOTION, 2014, 21 : 83 - 83
  • [23] Drug epidemiology and drug utilisation research based on health insurance data: Central research questions and methodological notes
    Schubert, Ingrid
    PRAVENTION UND GESUNDHEITSFORDERUNG, 2022,
  • [24] Drugs on Internet - What's at stake for public health?
    Allain, PY
    Schuck, S
    Beaufils, C
    Zekri, O
    Ganilsy, M
    Allain, H
    PRESSE MEDICALE, 1998, 27 (03): : 117 - 121
  • [25] Geography and health: what is at stake? History, themes and challenges
    Barcellos, Christovam
    Buzai, Gustavo D.
    Handschumacher, Pascal
    CONFINS-REVUE FRANCO-BRESILIENNE DE GEOGRAPHIE-REVISTA FRANCO-BRASILEIRA DE GEOGRAFIA, 2018, 37
  • [26] The Orphan Drug Act: An engine of innovation? At what cost?
    Rohde, DD
    FOOD AND DRUG LAW JOURNAL, 2000, 55 (01) : 125 - 143
  • [27] DRUG BENEFITS IN HEALTH INSURANCE
    MULLER, C
    INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1974, 4 (01): : 157 - 170
  • [28] What Makes Diseases and Drug Research and Development Attractive for the Pharmaceutical Industry
    Hanekom, Nicola
    Bam, Louzanne
    de Kock, Imke
    2019 IEEE INTERNATIONAL CONFERENCE ON ENGINEERING, TECHNOLOGY AND INNOVATION (ICE/ITMC), 2019,
  • [29] Applied Research of IoV in Insurance Industry
    BI Xiang
    LIU Zheng-yu
    LIU Ning-bo
    ZHANG Li
    Computer Aided Drafting,Design and Manufacturing, 2014, (02) : 54 - 59
  • [30] INSURANCE INDUSTRY AND BIOMEDICAL-RESEARCH
    APPELQUIST, CA
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (25): : 1674 - 1674
12345